21 April, 2017 by The TZ Newswire Staff Comments Off on Samsung Bioepis wins FDA approval for rheumatoid arthritis drug that competes with Johnson & Johnson
Samsung Bioepis wins FDA approval for rheumatoid arthritis drug that competes with Johnson & Johnson
Samsung Bioepis has won U.S. regulatory approval for key biosimilar drug.
21 April, 2017 by The TZ Newswire Staff Comments Off on The Moneyologist: The Moneyologist: My siblings bounced checks on my mom, so I kept $20,000 after she died
The Moneyologist: The Moneyologist: My siblings bounced checks on my mom, so I kept $20,000 after she died
This woman faces a lawsuit by her siblings to reclaim stolen money.
read more
21 April, 2017 by The TZ Newswire Staff Comments Off on Anyone profiting from Venezuela right now? If so, how?
Anyone profiting from Venezuela right now? If so, how?
Seems like government bonds were a decent alternative maybe 3 yrs ago, looks like they’re out of money at this point. Other than shorting GM and/or whatever is left to be nationalized, how are you making a buck out of what’s going on down there?
Seems like their only play is oil, which would devalue the barrel even further. So there’s money to be made there.
21 April, 2017 by The TZ Newswire Staff Comments Off on Julia Simon, Reuters
Julia Simon, Reuters
21 April, 2017 by The TZ Newswire Staff Comments Off on Context Summits Poll: Demand Rising for Alternative Assets and New Strategies
Context Summits Poll: Demand Rising for Alternative Assets and New Strategies
Institutional investors are broadly maintaining their commitments to the alternative investment industry and nearly three-quarters plan to increase their allocations this year, according to a new survey by Context Summits.
21 April, 2017 by The TZ Newswire Staff Comments Off on Man Group AUM Hits Record $88.7B As Q1 Inflows Soar
Man Group AUM Hits Record $88.7B As Q1 Inflows Soar
In a reflection of the increased allocations to hedge funds being reported by industry data providers Hedge Fund Research and eVestment in recent days, assets under management at London-based Man Group reached a record $88.7 billion during the first quarter.
21 April, 2017 by The TZ Newswire Staff Comments Off on Samsung’s Galaxy S8 Success Will Come at a Cost
Samsung’s Galaxy S8 Success Will Come at a Cost
By all indications thus far, Samsung‘s newest Galaxy S8 looks like it’s going to be a massive success. The new flagship handset has a striking and unique design that sets it apart from anything Apple (NASDAQ: AAPL) has done, and the company played it conservatively in terms of the battery specs in order to ensure that the Note 7 debacle doesn’t repeat itself. The Note 7’s explosive tendencies were in part tied to Samsung pushing the envelope with the battery’s energy density.